Clinical trial Recruiting at 1 site Interventional Ages 18 to 99

Additional HI-PEMF therapy after total hip replacement

Official title: Effects of Additional High-Intensity Pulsed Electromagnetic Field (HI-PEMF) Therapy on Pain and Physical Function After Total Hip Replacement: A Randomized Controlled Trial

Run by National Taiwan University Hospital · NCT07564427 · Data updated 2026-11-12

This study tests whether high-intensity pulsed electromagnetic fields can help reduce pain and improve daily function after hip replacement in adults who just had the surgery.

Quick facts

Study typeInterventional
Ages18 Years to 99 Years
SexAll
Enrollment40 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations1 site (Taipei)
StatusRecruiting
StartedApril 28, 2026
Main results expectedApril 30, 2027
Study endsJuly 30, 2027
Registry record updatedSeptember 24, 2026
Trial IDNCT07564427 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older who recently underwent primary unilateral total hip arthroplasty for hip osteoarthritis and are cleared for full weight-bearing within tolerance.

Probably not a fit

Patients who are not able to bear weight as advised, or with certain neurological, cognitive, or balance impairments, may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates the use of high-intensity pulsed electromagnetic field therapy (HI-PEMF) in conjunction with postoperative exercise for people who have undergone primary unilateral total hip arthroplasty due to hip osteoarthritis. Pain and physical function are the main outcomes, with the goal of determining if HI-PEMF provides additional relief and functional gains during recovery. Participants will engage in a postoperative exercise program while receiving HI-PEMF treatment to mirror real-world clinical settings. The study also aims to assess feasibility for future clinical adoption of magnetic field therapy in postoperative care. Enrollment considerations include age 18 or older and adequate weight-bearing status as evaluated by the surgeon.

Why it matters

Potential benefit: If successful, HI-PEMF could offer added pain relief and faster restoration of daily activities after hip replacement.

How similar studies have gone: Previous research on magnetic field therapies has shown mixed results; this study explores a novel combination with postoperative exercise to clarify potential benefits.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

A. Age 18 years or older.

B. Patients who have undergone primary unilateral total hip arthroplasty due to hip osteoarthritis.

C. Patients who, after postoperative evaluation by their surgeon, are advised to bear full weight within their tolerance.

Exclusion Criteria:

A. Patients who have not undergone primary hip arthroplasty.

B. Patients who are advised by their doctor to maintain non-weight-bearing or partial weight-bearing on the affected or unaffected side.

C. History of neurological deficits (e.g., sensory abnormalities, stroke, spinal cord injury, Parkinson's disease, multiple sclerosis).

D. Mini-Mental State Examination (MMSE) \< 24 (mild cognitive impairment).

E. Berger's Balance Scale (BBS) \< 40 (higher risk of falls).

F. Sensory abnormalities.

G. Before or after this exercise training, if pain in other areas (e.g., degenerative pain in the knee or spine) prevents movement, or if the hip joint still experiences pain on a Visual Analogue Scale (VAS) score of 4 or higher even after taking pain medication.

H. Known malignancy.

I. Schizophrenia, bipolar disorder, or substance addiction (e.g., alcohol, drug).

J. Pregnant woman.

K. Individuals with implanted stents, pacemakers, or those requiring treatment for arrhythmia.

L. Wearing a hearing aid.

Where it's running

  • College of Public Health, National Taiwan University
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.